Cargando…
Higher risk of neoplastic progression of Barrett’s esophagus in patients with systemic sclerosis
Autores principales: | Anilkumar, Mythri, Alkhayyat, Motasem, Grewal, Udhayvir S, Sanaka, Madhusudhan R, Thota, Prashanthi N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677510/ https://www.ncbi.nlm.nih.gov/pubmed/34925857 http://dx.doi.org/10.1093/gastro/goaa096 |
Ejemplares similares
-
Chemoprevention in Barrett’s esophagus and esophageal
adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021) -
Risk of progression of Barrett's esophagus in patients with cirrhosis
por: Apfel, Tehilla, et al.
Publicado: (2017) -
Indications, contraindications and limitations of endoscopic therapy
for Barrett’s esophagus and early esophageal adenocarcinoma
por: Rouphael, Carol, et al.
Publicado: (2020) -
Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here?
por: Singh, Tavankit, et al.
Publicado: (2018) -
Higher prevalence of colon polyps in patients with Barrett’s esophagus: a case-control study
por: Kumaravel, Arthi, et al.
Publicado: (2014)